1. Characterization of a novel IDH2‐R159H mutation in acute myeloid leukaemia: Effects on cell metabolism and differentiation.
- Author
-
Nardozza, Anna Maria, Guarnera, Luca, Travaglini, Serena, Ottone, Tiziana, Divona, Mariadomenica, De Bellis, Eleonora, Savi, Arianna, Banella, Cristina, Noguera, Nelida Ines, Di Fusco, Davide, Monteleone, Ivan, and Voso, Maria Teresa
- Subjects
- *
ACUTE myeloid leukemia , *CELL metabolism , *CELL differentiation , *GENETIC mutation , *KREBS cycle - Abstract
This article, published in the British Journal of Haematology, discusses a novel IDH2-R159H mutation found in a patient with acute myeloid leukaemia (AML). The mutation was acquired during disease progression and had a significant impact on cell metabolism and differentiation. The study also explores the sensitivity of the mutation to enasidenib, an oral inhibitor of mutant IDH2. The findings suggest that the presence of the IDH2-R159H mutation, along with another mutation, may be associated with a negative outcome and reduced response to enasidenib. The authors emphasize the importance of retesting for molecular changes during the course of the disease. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF